RxDoctor Payments Data

Jeannie Kilpela, APRN

Family · Cynthiana, KYNPI 1619265493

Payments from drug & device makers

$741in general payments, 2019–2025

Across 41 payments — averaging $18.08 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$110
  • Novo Nordisk$87
  • Novartis$74
  • Seqirus USA Inc$62
  • Amgen$61
  • GSK$55
  • plus $293 from 11 others

What the payments were for

  • Food & beverage$741100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$741 in reported general payments places this provider in the 55th percentile of 4,374 family providers in Kentucky.

See all family providers in Kentucky

Medicare billing

Part B allowed, 2024
$40,959
Medicare patients
199
Services billed
880

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide42$42,163
JardianceEmpagliflozin35$29,441
EliquisApixaban31$22,607
FarxigaDapagliflozin Propanediol12$12,777
Toujeo SolostarInsulin Glargine,hum.Rec.Anlog11$9,932
JanuviaSitagliptin Phosphate11$6,057
SymbicortBudesonide/Formoterol Fumarate20$4,434
Toujeo Max SolostarInsulin Glargine,hum.Rec.Anlog12$3,438
Albuterol Sulfate HfaAlbuterol Sulfate61$1,969
Lantus SolostarInsulin Glargine,hum.Rec.Anlog16$1,771
Levothyroxine Sodium208$1,520
Gabapentin155$1,377
Omeprazole133$1,045
Atorvastatin Calcium229$997
Diclofenac Sodium49$855

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$87$42,16342 claims
Boehringer IngelheimJardiance$43$29,44135 claims
PfizerEliquis$27$22,60731 claims
AstraZenecaFarxiga, Symbicort$13$17,21132 claims
AbbVieSynthroid$110$42013 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 55th percentile of 4,374 family providers in Kentucky.

Other family in Cynthiana

See the full list for Kentucky

Where these figures come from

Is this you, or does something look wrong? →